Your Bones Know: GLP-1s Cut Fracture Risk
There is a particular kind of fear that arrives quietly, somewhere in your forties.
Your Bones Know: GLP-1s Cut Fracture Risk
There is a particular kind of fear that arrives quietly, somewhere in your forties. Not the dramatic fear — not chest pain or a suspicious mole — but the slower one. The fear of becoming fragile. Of a fall that changes everything. I have watched it cross the faces of women I admire, women who run companies and speak four languages and still pause at the top of a staircase, thinking.
So the new data on GLP-1 medications — Ozempic, Mounjaro, Wegovy, the whole family that has spent the last two years dominating dinner conversation — caught my attention for a reason that had nothing to do with weight. A study published recently found that people with type 2 diabetes who take GLP-1 receptor agonists show a meaningfully lower risk of fragility fractures, those breaks that happen not from trauma but from bone that has quietly become less than it was.
This matters more than the headline suggests. Fragility fractures — hip, wrist, vertebrae — are one of the most underestimated health risks for people over fifty, and the connection between type 2 diabetes and bone health is genuinely underappreciated. Diabetic bone disease is real: elevated blood sugar disrupts the proteins that hold bone matrix together, creating bones that look dense on a scan but behave brittlely in a fall. The standard measurement, DEXA bone density, often misses this entirely, which is why so many diabetic patients are blindsided.
What the GLP-1 research suggests is that these medications may be doing something beneficial at the cellular level — reducing inflammation, improving metabolic signalling, or both — that makes bone more resilient. The mechanism is not fully understood yet, and the researchers are careful about that. But the signal is consistent enough across studies that it deserves serious attention.
None of this means GLP-1 drugs are a bone supplement. What it means is that the body is not a collection of separate problems. The medication you take for blood sugar affects your heart, your cognition, your anxiety levels, and now, apparently, your skeleton. Every system is talking to every other system, all the time. That is not a metaphor. It is just biology.
The practical thing, then, is not to wait for a fracture to start thinking about bone health. Weight-bearing exercise — walking, resistance training, anything that puts load through the skeleton — remains the most evidence-backed intervention available to everyone, regardless of medication status. Even thirty minutes of walking on Valletta's uneven baroque stone counts. The body knows what to do with resistance. Give it some.
Tomorrow: add one set of squats or a short walk to your morning. Your bones will file it away.
